Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Stereotactic Ablative Radiotherapy for Oligometastatic Non-small Cell Lung Cancer. A Randomised Phase II Trial

NCT02417662 is registered in ClinicalTrials.gov with University College, London as lead sponsor.

NCT NCT02417662
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02417662 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Stereotactic Ablative Radiotherapy for Oligometastatic Non-small Cell Lung Cancer. A Randomised Phase II Trial
Lead sponsor
University College, London
Phase
Not applicable
Overall status
Active, not recruiting
Start date
August 19, 2016
Completion date
August 31, 2028
Enrollment
140 (actual)
Sites
19

Conditions

As the registry lists them; a condition with its own page is linked.

non-small cell lung cancer